Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate

Acta Orthopaedica

Volumn 80, Issue 4, 2009, Pages 413-415

  Schilcher, Jörg ^a   Aspenberg, Per ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; FEMALE; FEMUR FRACTURE; HUMAN; INCIDENCE; MIDDLE AGED; PREVALENCE; RADIOGRAPHY; REGISTER; RISK FACTOR; STRESS FRACTURE; SWEDEN; TIME;

AGED; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; FEMORAL FRACTURES; FRACTURES, STRESS; HUMANS; INCIDENCE; MIDDLE AGED; PREVALENCE; REGISTRIES; RISK FACTORS; SWEDEN; TIME FACTORS;

EID: 74249108694     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.3109/17453670903139914     Document Type: Article

References (8)

1. Black D M, Cummings S R, Karpf D B, Cauley J A, Thompson D E, Nevitt M C, Bauer D C, Genant H K, Haskell W L, Marcus R, Ott S M, Torner J C, Quandt S A, Reiss T F and Ensrud K E. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996; 348(9041): 1535-41. (Pubitemid 26411651)
2. Black D M, Schwartz A V, Ensrud K E, Cauley J A, Levis S, Quandt S A, Satterfield S, Wallace R B, Bauer D C, Palermo L, Wehren L E, Lombardi A, Santora A C and Cummings S R. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. Jama 2006; 296(24): 2927-38. (Pubitemid 46021497)
3. Goh S K, Yang K Y, Koh J S, Wong M K, Chua S Y, Chua D T and Howe T S. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br 2007; 89(3): 349-53. (Pubitemid 46563912)
4. Kwek E B, Goh S K, Koh J S, Png M A and Howe T S. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 2008a; 39(2): 224-31.
5. Kwek E B, Koh J S and Howe T S. More on atypical fractures of the femoral diaphysis. N Engl J Med 2008b; 359(3): 316-7; author reply 317-8. (Pubitemid 352008464)
6. Lenart B A, Lorich D G and Lane J M. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 2008; 358(12): 1304-6. (Pubitemid 351439247)
7. Neviaser A S, Lane J M, Lenart B A, Edobor-Osula F and Lorich D G. Lowenergy femoral shaft fractures associated with alendronate use. J Orthop Trauma 2008; 22(5): 346-50. (Pubitemid 351630250)
8. Sayed-Noor A S and Sjöden G O. Subtrochanteric displaced insufficiency fracture after long-term alendronate therapy - a case report. Acta Orthop 2008; 79(4): 565-7.